Breathe Life Sciences (BXN:ASX) is an Australian multi-national life sciences company focused on research, development, manufacture, and wholesale of novel pharmaceuticals, medicinal cannabis, psilocybin, consumer health and lifestyle products.
In 2023 BLS was acquired by Bioxyne (BXN:ASX). The merged group has head offices in Sydney, London, Prague, and Nagoya.
The Company operates in Australia, the United Kingdom, Germany, France, Czechia, Japan, and the United States.
https://bioxyne.com/
Company Details
- Employees
- 34
- Founded
- -
- Address
- Meadowbrook, Brisbane,qld,australia
- Industry
- Biotechnology
- Website
- https://breathelifesciences.com/
- Keywords
- Pharmaceutical GMP, White Label Manufacture, CBD, Nootropics, Health Supplements, Skin Care, Research & Development, Clinical Trials, Medical Cannabis, Psilocybin, Telemedicine, Chain Of Custody, Import, Export, Manufacture, Medicine Technology.
- HQ
- Brisbane, QLD
Breathe Life Sciences (Bxn:asx) Questions
Breathe Life Sciences (Bxn:Asx)'s website is https://breathelifesciences.com/
Breathe Life Sciences (Bxn:Asx)'s LinkedIn profile is https://au.linkedin.com/company/breathe-life-sciences
Breathe Life Sciences (Bxn:Asx) has
34 employees.
View email and phone details for 34
employees at Breathe Life Sciences (Bxn:Asx).
Breathe Life Sciences (Bxn:Asx)'s industry is
Biotechnology
Breathe Life Sciences (Bxn:Asx)'s top competitors are
Dr Watson,
Bioxyne Ltd,
Tendl,
Kind Medical,
Hapana,
Montu,
Proto Axiom,
Always Pure Organics Ltd,
Kinoxis Therapeutics Pty Ltd,
Australian Medical Angels.
Breathe Life Sciences (Bxn:Asx)'s categories are Biotechnology
Breathe Life Sciences (Bxn:Asx)'s founding year is 2018
